E. Wilson Troy's Insider Trades & SAST Disclosures
E. Wilson Troy's most recent trade in Kura Oncology Inc was a trade of 625,000 Option to purchase common stock done . Disclosure was reported to the exchange on Jan. 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern E. Wilson Troy.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 625,000 | 625,000 | - | - | Option to purchase common stock | |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 27,000 | 27,350 (0%) | 0% | 0 | Common Stock | |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Sale of securities on an exchange or to another person at price $ 3.33 per share. | 13 Jun 2024 | 27,000 | 350 (0%) | 0% | 3.3 | 89,902 | Common Stock |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 13,489 | 13,489 | - | - | Stock Option (Right to Buy) | |
| Kura Oncology Inc | E. Troy Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.23 per share. | 24 Jan 2024 | 84,107 | 559 (0%) | 0% | 20.2 | 1,701,485 | Common Stock |
| Kura Oncology Inc | E. Troy Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.15 per share. | 24 Jan 2024 | 84,107 | 84,666 (0%) | 0% | 6.1 | 517,258 | Common Stock |
| Kura Oncology Inc | Wilson E. Troy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.23 per share. | 24 Jan 2024 | 6,945 | 559 (0%) | 0% | 20.2 | 140,497 | Common Stock |
| Kura Oncology Inc | Wilson E. Troy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.80 per share. | 24 Jan 2024 | 6,945 | 7,504 (0%) | 0% | 4.8 | 33,336 | Common Stock |
| Kura Oncology Inc | Wilson Troy E. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 560,000 | 560,000 | - | - | Option to purchase common stock | |
| Avidity Biosciences Inc | Wilson Troy E. | Director | Other type of transaction at price $ 0.00 per share. | 12 Dec 2023 | 300,000 | 263,711 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Other type of transaction at price $ 0.00 per share. | 12 Dec 2023 | 300,000 | 300,000 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Troy Wilson E. | Director | Other type of transaction at price $ 0.00 per share. | 12 Dec 2023 | 250,000 | 13,711 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Troy Wilson E. | Director | Other type of transaction at price $ 0.00 per share. | 12 Dec 2023 | 250,000 | 300,000 | - | 0 | Common Stock | |
| Kura Oncology Inc | E. Wilson Troy | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Dec 2023 | 2,000 | 559 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy Wilson E. | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Dec 2023 | 1,000 | 279,194 (0%) | 0% | 0 | Common Stock | |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 27,000 | 27,350 (0%) | 0% | 0 | Common Stock | |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Sale of securities on an exchange or to another person at price $ 3.45 per share. | 13 Jun 2023 | 27,000 | 350 (0%) | 0% | 3.5 | 93,269 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 02 Jun 2023 | 300,000 | 300,000 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 02 Jun 2023 | 300,000 | 280,194 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 02 Jun 2023 | 300,000 | 580,194 (1%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 02 Jun 2023 | 212,500 | 880,194 (1%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 02 Jun 2023 | 41,318 | 1,092,694 (2%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 02 Jun 2023 | 27,966 | 2,559 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 02 Jun 2023 | 8,394 | 0 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 02 Jun 2023 | 8,394 | 1,134,012 (2%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2022 | 1,084,300 | 1,125,618 (2%) | 2% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2022 | 1,084,300 | 8,394 (0%) | 2% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 560,000 | 560,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2022 | 468,297 | 1,151,720 (2%) | 1% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2022 | 41,318 | 1,092,694 (2%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2022 | 41,318 | 41,318 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2022 | 17,708 | 1,134,012 (2%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 14 Jul 2022 | 11,985 | 30,525 (0%) | 0% | 0 | Common Stock | |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Sale of securities on an exchange or to another person at price $ 2.58 per share. | 16 Jun 2022 | 27,858 | 27,350 (0%) | 0% | 2.6 | 71,971 | Common Stock |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 27,000 | 55,208 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 495,000 | 495,000 | - | - | Option to purchase common stock | |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 27,858 | 28,208 (0%) | 0% | 0 | COMMON STOCK | |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Other type of transaction at price $ 0.00 per share. | 22 Dec 2020 | 100,000 | 100,000 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Troy E. Wilson | Director | Other type of transaction at price $ 0.00 per share. | 22 Dec 2020 | 100,000 | 89,618 | - | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 11,855 | 90,210 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.15 per share. | 01 Dec 2020 | 11,855 | 39,951 (0%) | 0% | 6.1 | 72,908 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 06 Oct 2020 | 106,736 | 0 (0%) | 0% | 34 | 3,629,024 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 32.00 per share. | 06 Oct 2020 | 99,900 | 106,736 (0%) | 0% | 32 | 3,196,800 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2020 | 50,370 | 102,065 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 06 Oct 2020 | 50,370 | 28,096 (0%) | 0% | 34 | 1,712,580 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.15 per share. | 06 Oct 2020 | 50,370 | 78,466 (0%) | 0% | 6.2 | 309,776 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2020 | 4,586 | 152,435 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 06 Oct 2020 | 4,586 | 28,096 (0%) | 0% | 34 | 155,924 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.15 per share. | 06 Oct 2020 | 4,586 | 32,682 (0%) | 0% | 6.2 | 28,204 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 32.00 per share. | 06 Oct 2020 | 100 | 206,636 (0%) | 0% | 32 | 3,200 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 28.82 per share. | 11 Sep 2020 | 98,490 | 206,736 (0%) | 0% | 28.8 | 2,838,876 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.15 per share. | 11 Sep 2020 | 17,926 | 46,022 (0%) | 0% | 6.2 | 110,245 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2020 | 17,926 | 157,021 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 11 Sep 2020 | 17,926 | 28,096 (0%) | 0% | 28 | 501,928 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 11 Sep 2020 | 485 | 305,226 (0%) | 0% | 28 | 13,580 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 08 Sep 2020 | 50,000 | 306,736 (0%) | 0% | 26 | 1,300,000 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.15 per share. | 08 Sep 2020 | 37,030 | 65,126 (0%) | 0% | 6.2 | 227,735 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 08 Sep 2020 | 37,030 | 28,096 (0%) | 0% | 28 | 1,036,840 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2020 | 37,030 | 174,947 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 08 Sep 2020 | 1,025 | 305,711 (0%) | 0% | 28 | 28,700 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.37 per share. | 24 Aug 2020 | 23,053 | 28,096 (0%) | 0% | 22.4 | 515,788 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2020 | 22,838 | 211,977 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.15 per share. | 24 Aug 2020 | 22,838 | 50,934 (0%) | 0% | 6.2 | 140,454 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.80 per share. | 24 Aug 2020 | 6,568 | 34,664 (0%) | 0% | 4.8 | 31,526 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2020 | 6,568 | 7,160 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.04 per share. | 24 Aug 2020 | 6,568 | 28,096 (0%) | 0% | 22.0 | 144,770 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2020 | 215 | 6,945 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.80 per share. | 24 Aug 2020 | 215 | 51,149 (0%) | 0% | 4.8 | 1,032 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 17 Aug 2020 | 50,000 | 356,736 (0%) | 0% | 22 | 1,100,000 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Aug 2020 | 26,041 | 1,795,017 (3%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Aug 2020 | 26,041 | 28,096 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2020 | 12,901 | 26,162 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 17 Aug 2020 | 12,901 | 28,096 (0%) | 0% | 22.0 | 283,868 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.80 per share. | 17 Aug 2020 | 12,901 | 40,997 (0%) | 0% | 4.8 | 61,925 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2020 | 11,913 | 13,728 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.09 per share. | 17 Aug 2020 | 11,913 | 28,096 (0%) | 0% | 22.1 | 263,196 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.80 per share. | 17 Aug 2020 | 11,913 | 40,009 (0%) | 0% | 4.8 | 57,182 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 17 Aug 2020 | 521 | 28,096 (0%) | 0% | 22 | 11,462 | Common Stock |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2020 | 521 | 25,641 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Troy E. Wilson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.80 per share. | 17 Aug 2020 | 521 | 28,617 (0%) | 0% | 4.8 | 2,501 | Common Stock |
| Avidity Biosciences Inc | Troy E. Wilson | Director | 16 Jun 2020 | 254,907 | 0 | - | - | Series A Preferred Stock | ||
| Avidity Biosciences Inc | Troy E. Wilson | Director | 16 Jun 2020 | 189,042 | 805,301 | - | - | Common Stock | ||
| Avidity Biosciences Inc | Troy E. Wilson | Director | 16 Jun 2020 | 108,504 | 0 | - | - | Series C Preferred Stock | ||
| Avidity Biosciences Inc | Troy E. Wilson | Director | 16 Jun 2020 | 35,374 | 0 | - | - | Series B Preferred Stock | ||
| Puma Biotechnology Inc | Troy E. Wilson | Director | Sale of securities on an exchange or to another person at price $ 9.97 per share. | 11 Jun 2020 | 25,245 | 26,098 (0%) | 0% | 10.0 | 251,693 | COMMON STOCK |
| Puma Biotechnology Inc | Troy E. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2020 | 25,748 | 51,343 (0%) | 0% | 0 | COMMON STOCK |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges